NFE2L2 and neoplasm: In the present case, whole-exome sequencing of the tumor revealed somatic mutations in well-known cancer-driver genes such as CTNNB1 and NFE2L2; interestingly, mutations frequently identified in bile-duct cancers and IPNB, such as KRAS and GNAS mutations, were not found (Table 1).